Resistance to quinclorac and ALS-inhibitor herbicides in Galium spurium is conferred by two distinct genes

Summary Classical Mendelian experiments were conducted to determine the genetics and inheritance of quinclorac and acetolactate synthase (ALS)‐inhibitor resistance in a biotype of Galium spurium. Plants were screened with the formulated product of either quinclorac or the ALS‐inhibitor, thifensulfur...

Full description

Saved in:
Bibliographic Details
Published inWeed research Vol. 44; no. 5; pp. 355 - 365
Main Authors Van Eerd, L.L, McLean, M.D, Stephenson, G.R, Hall, J.C
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Science Ltd 01.10.2004
Blackwell Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Summary Classical Mendelian experiments were conducted to determine the genetics and inheritance of quinclorac and acetolactate synthase (ALS)‐inhibitor resistance in a biotype of Galium spurium. Plants were screened with the formulated product of either quinclorac or the ALS‐inhibitor, thifensulfuron, at the field dose of 125 or 6 g active ingredient (a.i.) ha−1 respectively. Segregation in the F2 generation indicated that quinclorac resistance was a single, recessive nuclear trait, based on a 1 : 3 segregation ratio [resistant : susceptible (R : S)]. Resistance to ALS inhibitors was due to a single, dominant nuclear trait, segregating in the F2 generation in a 3 : 1 ratio (R : S). The genetic models were confirmed by herbicide screens of F1 and backcrosses between the F1 and the S parent. F2 plants that survived quinclorac treatment set seed and the resulting F3 progeny were screened with either herbicide. Quinclorac‐treated F3 plants segregated in a 1 : 0 ratio (R : S), hence F2 progenitors were homozygous for quinclorac resistance. In contrast, F3 progeny segregated into three ratios: 1 : 0, 3 : 1 and 0 : 1 (R : S) in response to ALS‐inhibitor treatment. This segregation pattern indicates that their F2 parents were either homozygous or heterozygous for ALS‐inhibitor resistance. Therefore, there were clearly two distinct resistance mechanisms encoded by two genes that were not tightly linked as demonstrated by segregation patterns of the F3.
Bibliography:ArticleID:WRE408
ark:/67375/WNG-D32VP2K3-D
istex:9B4D2339F7EDF325A6E9D75AF6C5DFDD82BC7FE2
Present address: L L Van Eerd, Ridgetown College, University of Guelph, Ridgetown, Ontario, Canada N0P 2C0
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0043-1737
1365-3180
DOI:10.1111/j.1365-3180.2004.00408.x